Molecular approaches to the spreading problem of drug resistant malaria

Advances in Experimental Medicine and Biology

Volumn 390, Issue , 1996, Pages 197-209

  Plowe, Christopher V ^a   Wellems, Thomas E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; FOLIC ACID ANTAGONIST; PROGUANIL; PYRIMETHAMINE; SULFONAMIDE;

ANTIBIOTIC THERAPY; CONFERENCE PAPER; DNA FINGERPRINTING; GENETIC ANALYSIS; HUMAN; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; CHROMOSOME MAPPING; DNA FINGERPRINTING; DNA, PROTOZOAN; DRUG RESISTANCE, MULTIPLE; FOLIC ACID ANTAGONISTS; HUMANS; MALARIA; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; POINT MUTATION; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 0030021215     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (48)

1. P. Guttman and P. Ehrlich, Ueber die Wirkung des methylenblau bei malaria, Berlin Klin Wochenschr. 28:953-956 1891.
2. L.J. Bruce-Chwatt(ed.), R.H. Black, C.J. Canfield, D.F. Clyde, W. Peters, and W.H. Wernsdorfer, Chemotherapy of Malaria, World Health Organization, Geneva, 1986.
3. D.F. Clyde, Variations in response of malaria parasites to drugs in Asia and Oceania, Med. Trop. Cooperaz. Sviluppo 3:3-22 (1987).
4. D.F. Clyde, Genesis of chloroquine-resistant Plasmodium falciparum in the American region, Med Trop Cooperaz Sviluppo 3:41-44 1987.
5. A.S. Jones, Mass treatment with pyrimethamine. A study of resistance and cross resistance resulting from a field trial in the hyperendemic malarious area of Makueni, Kenya, September 1952-September 1953, Trans R Soc Trop Med Hyg 52:547-561 (1958).
6. T. Wilson and J.F.B. Edeson, Treatment of acute malaria with pyrimethamine, British Medical Journal 1:253-255 (1953).
7. P.B. Bloland, E.M. Lackritz, P.N. Kazembe, J.B.O. Were, R. Steketee, and C.C. Campbell, Beyond chloroquine: Implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis. 167:932-937 (1993).
8. World Health Organization Technical Report Series, World Health Organization, Geneva, (1990).
9. F. Gay, D.G. Bustos, B. Diquet, L. Rojas Rivero, M. Litaudon, C. Pichet, M. Danis, and M. Gentilini, Cross-resistance between mefloquine and halofantrine [letter], Lancet 336:1262(1990).
10. S.R. Meshnick, Y.Z. Yang, V. Lima, F. Kuypers, S. Kamchonwongpaisan, and Y. Yuthavong, Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu), Antimicrob. Agents Chemother. 37:1108-1114 (1993).
11. T.T. Hien and N.J. White, Qinghaosu, Lancet 341:603-608 (1993).
12. N.J. White, D. Waller, J. Crawley, F. Nosten, D. Chapman, D. Brewster, and B.M. Greenwood, Comparison of artemether and chloroquine for severe malaria in Gambian children, Lancet 339:317-321 (1992).
13. S. Looareesuwan, C. Viravan, S. Vanijanonta, P. Wilairatana, P. Suntharasamai, P. Charoenlarp, K. Arnold, D. Kyle, C. Canfield, and K. Webster, Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria, Lancet 339:821-824 (1992).
14. S. Looareesuwan, P. Wilairatana, S. Vanijanonta, D. Kyle, and K. Webster, Efficacy of quinine-tetracycline for acute uncomplicated falciparum malaria in Thailand [letter], Lancet 339:369(1992).
15. G. Watt, L. Loesuttivibool, G.D. Shanks, E.F. Boudreau, A.E. Brown, K. Pavanand, H.K. Webster, and S. Wechgritaya, Quinine with tetracycline for the treatment of drug-resistant falciparum malaria in Thailand, Am. J. Trop. Med. Hyg. 47:108-111 (1992).
16. C.C. Campbell, Challenges facing antimalarial therapy in Africa, J. Infect. Dis. 163:1207-1211 (1991).
17. A.F.G. Slater and A. Cerami, Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature 355:167-169 (1992).
18. A. Yayon, Z.I. Cabantchik, and H. Ginsburg, Susceptibility of human malaria parasites to chloroquine is pH dependent, Proc. Natl. Acad. Sci. U. S. A. 82:2784-2788 (1985).
19. D.J. Krogstad, I.Y. Gluzman, D.E. Kyle, A.M. Oduola, S.K. Martin, W.K. Milhous, and P.H. Schlesinger, Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance, Science 238:1283-1285 (1987).
20. P.G. Bray, R.E. Howells, G.Y. Ritchie, and S.A. Ward, Rapid chloroquine efflux phenotype in both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. A correlation of chloroquine sensitivity with energy-dependent drug accumulation, Biochem. Pharmacol. 44:1317-1324 (1992).
21. S.K. Martin, A.M. Oduola, and W.K. Milhous, Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235:899-901 (1987).
22. A.J. Bitonti, A. Sjoerdsma, P.P. McCann, D.E. Kyle, A.M. Oduola, R.N. Rossan, W.K. Milhous, and D.E. Davidson, Jr., Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine, Science 242:1301-1303 (1988).
23. M. Warsame, W.H. Wernsdorfer, and A. Bjorkman, Lack of effect of desipramine on the response to chloroquine of patients with chloroquine-resistant falciparum malaria, Trans. R. Soc. Trop. Med. Hyg. 86:235-236 (1992).
24. A.J. Bitonti and P.P. McCann, Desipramine and cyproheptadine for reversal of chloroquine resistance in Plasmodium falciparum [letter], Lancet 2:1282-1283 (1989).
25. C.M. Wilson, A.E. Serrano, A. Wasley, M.P. Bogenschutz, A.H. Shankar, and D.F. Wirth, Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum, Science 244:1184-1186 (1989).
26. S.J. Foote, J.K. Thompson, A.F. Cowman, and D.J. Kemp, Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum, Cell 57:921-930 (1989).
27. S.J. Foote, D.E. Kyle, R.K. Martin, A.M. Oduola, K. Forsyth, D.J. Kemp, and A.F. Cowman, Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345:255-258 (1990).
28. T.E. Wellems, L.J. Panton, I.Y. Gluzman, V.E. do Rosario, R.W. Gwadz, A. Walker-Jonah, and D.J. Krogstad, Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature 345:253-255 (1990).
29. C.M. Wilson, S.K. Volkman, S. Thaithong, R.K. Martin, D.E. Kyle, W.K. Milhous, and D.F. Wirth, Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium fafciparum from Thailand, Mol. Biochem. Parasitol. 57:151-160 (1993).
30. F.M. Awad-el-Kariem, M.A. Miles, and D.C. Warhurst, Chloroquine-resistant Plasmodium falciparum isolates from the Sudan lack two mutations in the pfmdr 1 gene thought to be associated with chloroquine resistance, Trans. R. Soc. Trop. Med. Hyg. 86:587-589 (1992).
31. T.E. Wellems, A. Walker-Jonah, and L.J. Panton, Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7. Proc. Natl. Acad. Sci. U. S. A. 88:3382-3386 (1991).
32. D.S. Peterson, D. Walliker, and T.E. Wellems, Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria, Proc. Natl. Acad. Sci. U. S. A. 85:9114-9118 (1988).
33. A.F. Cowman, M.J. Morry, B.A. Biggs, G.A. Cross, and S.J. Foote, Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum, Proc. Natl. Acad. Sci. U. S. A. 85:9109-9113 (1988).
34. J.W. Zolg, J.R. Plitt, G. Chen, and S. Palmer, Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum, Mol. Biochem. Parasitol. 36:253-262 (1989).
35. D.S. Peterson, W.K. Milhous, and T.E. Wellems, Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria, Proc. Natl. Acad. Sci. U. S. A. 87:3018-3022 (1990).
36. S.J. Foote, D. Galatis, and A.F. Cowman, Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance, Proc. Natl. Acad. Sci. U. S. A. 87:3014-3017 (1990).
37. D.S. Peterson, S.M. di Santi, M. Povoa, V.S. Calvosa, V.E. do Rosario, and T.E. Wellems, Prevalence of the dihydrofolate reductase Asn-108 mutation as the basis for pyrimethamine-resistant falciparum malaria in the Brazilian Amazon, Am. J. Trop. Med. Hyg. 45:492-497 (1991).
38. W.K. Milhous, D.S. Peterson, T.E. Wellems, E.K. Lehnert, L. Gerena, S.L. Andersen, and B.G. Schuster, New alternatives to cycloguanil and pyrimethamine. Programs & Abstracts of the 40th Annual Meeting of the American Society of Tropical Medicine & Hygiene 45:(1991).(Abstract)
39. C.J. Canfield, W.K. Milhous, A.L. Ager, R.N. Rossan, T.R. Sweeney, N.J. Lewis, and D.P. Jacobus, PS-15: A potent orally active antimalarial from a new class of folic acid antagonists, Am. J. Trop. Med. Hyg. 49:121-126 (1993).
40. D.R. Brooks, P. Wang, M. Read, W.M. Watkins, P.F.G. Sims, and J.E. Hyde, Sequence variation of the hydroxymethyldihydropterin pyrophospohkinase-dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine, Eur J Biochem. 224:397-405 (1994).
41. T. triglia and A.F. Cowman, Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum, Proc Natl Acad Sci USA. 85:7149-7153 (1994).
42. M.J. Gardner, D.H. Williamson, and R.J.M. Wilson, A circular DNA in malaria parasites encodes an RNA polymerase like that of prokaryotes and chloroplasts, Mol. Biochem. Parasitol. 44:115-124 (1991).
43. A.A. Gajadhar, W.C. Marquardt, R. Hall, J. Gunderson, E.V. Ariztia-Carmona, and M.L. Sogin, Ribosomal RNA sequences of Sarcocystis muris, Theileria annulata and Crypthecodinium cohnii reveal evolutionary relationships among apicomplexans, dinoflagellates, and ciliates, Mol. Biochem. Parasitol. 45:147-154 (1991).
44. A.B. Vaidya, R. Akella, and K. Suplick, Sequences similar to genes for two mitochondrial proteins and portions of ribosomal RNA in tandemly arrayed 6-kilobase-pair DNA of a malarial parasite, Mol. Biochem. Parasitol. 35:97-108 (1989).
45. R. Kiatfuengfoo, T. Suthiphongchai, P. Prapunwattana, and Y. Yuthavong, Mitochondria as the site of action of tetracycline on Plasmodium falciparum, Mol. Biochem. Parasitol. 34:109-115 (1989).
46. P.G. Kremsner, Clindamycin in malaria treatment, J. Antimicrob. Chemother. 25:9-14 (1990).
47. M. Strath, T. Scott-Finnigan, M. Gardner, D. Williamson, and I. Wilson, Antimalarial activity of rifampicin in vitro and in rodent models, Trans. R. Soc. Trop. Med. Hyg. 87:211-216 (1993).
48. W.E. Gutteridge, Antimalarial drugs currently in development, J. R. Soc. Med. 82 Suppl 17:63-6; discuss (1989).